Generate's head of R&D returns to Merck; Galapagos shuffles leadership team

→ Alexandra Snyder has bid adieu to Flagship's Generate:Medicines, which slashed its headcount by 10% last week, after three years as CMO and EVP, R&D, and is returning to her old stomping ...